Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Surg Res ; 53(4): 362-8, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1405617

ABSTRACT

Epicardial adhesions are believed to form secondarily to impaired pericardial fibrinolytic activity. This activity was reconstituted in a rabbit pericardial adhesion model with single doses of the fibrinolytic agents tissue plasminogen activator (t-PA), t-PA analog (Fb-Fb-CF), and streptokinase (SK), resulting in reductions in the extent and tenacity of adhesion formation. Adhesions of the median strip of the anterior cardiac surface were reduced in area from 89% (n = 22) in controls, to 28% (n = 5) by treatment with Fb-Fb-CF (0.94 mg), and to 49% (n = 7) by treatment with SK (93,750 IU). A modified fabric of oxidized regenerated cellulose (mTC7) used to deliver the agent to the cardiac surface did not interfere with the activity of these agents (Fb-Fb-CF 19%, n = 14; SK 33%, n = 7). t-PA (0.94 mg) was also found to reduce adhesion formation in combination with mTC7 (4%, n = 4), although the appearance of significant postoperative bruising and bleeding resulted in a decision to terminate the treatment of further animals with t-PA with and without mTC7. Postoperative bruising, bleeding, and swelling, to a lesser extent, were associated with SK and Fb-Fb-CF. Despite the efficacy of the these fibrinolytic drugs further work is required to assess their safety before they are used clinically.


Subject(s)
Fibrinolytic Agents/therapeutic use , Heart Diseases/prevention & control , Pericardium , Tissue Adhesions/prevention & control , Animals , Cellulose , Drug Carriers , Female , Fibrinolytic Agents/administration & dosage , Male , Peptide Fragments/administration & dosage , Peptide Fragments/therapeutic use , Postoperative Complications , Rabbits , Recombinant Proteins/administration & dosage , Recombinant Proteins/therapeutic use , Staphylococcal Protein A/administration & dosage , Staphylococcal Protein A/therapeutic use , Streptokinase/administration & dosage , Streptokinase/therapeutic use , Tissue Plasminogen Activator/administration & dosage , Tissue Plasminogen Activator/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...